Dr. Rodney S. Daniel, MD MSCR
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Miami, Lm Miller School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 386
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: University of Miami, Lm Miller School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
FL license ME108707
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Josephs Hospital Tampa, FL
- Morton Plant Hospital Clearwater, FL
Medical groups
- American Arthritis and Rheumatology Associates LLC (65 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 386
- Services billed
- 268,932
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, tocilizumab, 1 mg | 91,600 | 25 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 43,010 | 23 |
| Injection, romosozumab-aqqg, 1 mg | 23,100 | 27 |
| Injection, golimumab, 1 mg, for intravenous use | 17,640 | 27 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,650 | 23 |
| Injection, denosumab, 1 mg | 9,840 | 101 |
| Administration of chemotherapy into vein, 1 hour or less | 594 | 97 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 527 | 143 |
| Insertion of needle into vein for collection of blood sample | 433 | 166 |
| Established patient office or other outpatient visit, 30-39 minutes | 431 | 264 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Oldsmar, FL | 356 |
| Prednisone Other prescribers in Oldsmar, FL | 160 |
| Methotrexate (methotrexate sodium) Other prescribers in Oldsmar, FL | 146 |
| Rinvoq (upadacitinib) | 110 |
| Leflunomide Other prescribers in Oldsmar, FL | 100 |
| Duloxetine Hcl Other prescribers in Oldsmar, FL | 97 |
| Tramadol Hcl Other prescribers in Oldsmar, FL | 93 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Oldsmar, FL | 83 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Oldsmar, FL | 71 |
| Hydroxychloroquine Sulfate Other prescribers in Oldsmar, FL | 70 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 377 payments worth $144,950 in total to this clinician.
| Genzyme Corporation | $84,645 |
|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22,695 |
| AbbVie Inc. | $20,126 |
| AstraZeneca Pharmaceuticals LP | $9,944 |
| Invivyd Inc | $2,013 |
| Novartis Pharmaceuticals Corporation | $1,366 |
| Amgen Inc. | $922 |
| UCB, Inc. | $490 |
| Compensation for services other than consulting (speaking, faculty) | $107,099 |
|---|---|
| Consulting Fee | $15,728 |
| Travel and Lodging | $13,481 |
| Food and Beverage | $8,564 |
| Education | $77.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $8,268 |
| Genzyme Corporation Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $8,268 |
| Genzyme Corporation Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,950 |
| Genzyme Corporation May 18, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,950 |
| Genzyme Corporation Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,950 |
| Genzyme Corporation Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,632 |
| Genzyme Corporation Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $6,678 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 8, 2025 | Consulting Fee | $4,180 |
| Genzyme Corporation Aug 4, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $4,134 |
| AbbVie Inc. Aug 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,675 |
All 77 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Dec 15, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $226 |
| AbbVie Inc. Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $1,575 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 13, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $30.11 |
| Genzyme Corporation Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,950 |
| Genzyme Corporation Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $2,862 |
| Genzyme Corporation Nov 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Snellville, GA · in-kind | $677 |
| Genzyme Corporation Nov 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Lilburn, GA | $313 |
| Genzyme Corporation Nov 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Lilburn, GA · in-kind | $209 |
| Genzyme Corporation Nov 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Lilburn, GA | $56.00 |
| AstraZeneca Pharmaceuticals LP Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) SAPHNELO · Inflammation and Autoimmunity Company’s descriptionSpeaker Fee | $3,250 |
| AstraZeneca Pharmaceuticals LP Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) SAPHNELO · Inflammation and Autoimmunity Company’s descriptionSpeaker Fee | $3,250 |
| AbbVie Inc. Nov 4, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to VALDOSTA, GA · in-kind | $378 |
| AstraZeneca Pharmaceuticals LP Oct 31, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Colleyville, TX · in-kind Company’s descriptionSpeaker Expenses | $204 |
| AstraZeneca Pharmaceuticals LP Oct 31, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Colleyville, TX · in-kind Company’s descriptionSpeaker Expenses | $144 |
| Invivyd Inc Oct 30, 2025 | Consulting Fee PEMGARDA · INFECTIOUS DISEASE | $2,013 |
| AstraZeneca Pharmaceuticals LP Oct 30, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Waco, TX · in-kind Company’s descriptionSpeaker Expenses | $1,914 |
| AstraZeneca Pharmaceuticals LP Oct 30, 2025 | Travel and Lodging SAPHNELO · Inflammation and Autoimmunity · travel to Waco, TX · in-kind Company’s descriptionSpeaker Expenses | $194 |
| AbbVie Inc. Oct 24, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,675 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 8, 2025 | Consulting Fee | $4,180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 30, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $380 |
| AstraZeneca Pharmaceuticals LP Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) SAPHNELO · Inflammation and Autoimmunity Company’s descriptionSpeaker Fee | $600 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Aug 28, 2025 | Consulting Fee | $3,135 |
| Genzyme Corporation Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $6,678 |
| Genzyme Corporation Aug 20, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Miami, FL · in-kind | $573 |
| Genzyme Corporation Aug 20, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Miami, FL · in-kind | $401 |
| Genzyme Corporation Aug 20, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Miami, FL | $28.00 |
| Genzyme Corporation Aug 20, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Miami, FL | $21.00 |
| Genzyme Corporation Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $2,862 |
| Genzyme Corporation Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,632 |
| Genzyme Corporation Aug 14, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Las Vegas, NV · in-kind | $1,074 |
| Genzyme Corporation Aug 14, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Las Vegas, NV · in-kind | $914 |
| Genzyme Corporation Aug 14, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Las Vegas, NV · in-kind | $316 |
| AbbVie Inc. Aug 14, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $244 |
| Genzyme Corporation Aug 14, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Las Vegas, NV | $134 |
| Genzyme Corporation Aug 14, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Las Vegas, NV | $56.00 |
| AbbVie Inc. Aug 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,675 |
| AbbVie Inc. Aug 6, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,675 |
| AbbVie Inc. Aug 5, 2025 | Compensation for services other than consulting (speaking, faculty) SKYRIZI · IMMUNOLOGY | $1,575 |
| Genzyme Corporation Aug 4, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $4,134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Aug 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,840 |
| AbbVie Inc. Jul 17, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $122 |
| AbbVie Inc. Jul 7, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to ROSEMONT, IL · in-kind | $56.00 |
| AbbVie Inc. Jul 7, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to ROSEMONT, IL · in-kind | $24.00 |
| AbbVie Inc. Jul 7, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to ROSEMONT, IL · in-kind | $21.00 |
| AbbVie Inc. Jul 1, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,310 |
| AbbVie Inc. Jun 5, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to ROSEMONT, IL · in-kind | $605 |
| AbbVie Inc. Jun 5, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to ROSEMONT, IL · in-kind | $238 |
| AbbVie Inc. Jun 5, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to ROSEMONT, IL · in-kind | $184 |
| AbbVie Inc. Jun 5, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to ROSEMONT, IL · in-kind | $80.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 22, 2025 | Consulting Fee OFEV · RESPIRATORY | $3,600 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 22, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Miramar Beach, FL · in-kind | $140 |
| Genzyme Corporation May 18, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,950 |
| Janssen Biotech, Inc. May 9, 2025 | Education TREMFYA · Immunology · in-kind | $77.99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,840 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 28, 2025 | Travel and Lodging travel to Miramar Beach, FL · in-kind | $534 |
| Genzyme Corporation Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $3,180 |
| Genzyme Corporation Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $2,862 |
| Genzyme Corporation Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $8,268 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Saint Louis, MO · in-kind | $861 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Saint Louis, MO · in-kind | $300 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Saint Louis, MO | $56.00 |
| Genzyme Corporation Apr 10, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Saint Louis, MO | $21.00 |
| Genzyme Corporation Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $2,226 |
| Genzyme Corporation Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $8,268 |
| Genzyme Corporation Mar 6, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Glendale, AZ | $74.67 |
| Genzyme Corporation Mar 6, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Glendale, AZ | $63.83 |
| Genzyme Corporation Mar 6, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Glendale, AZ | $48.00 |
| Genzyme Corporation Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $7,950 |
| Genzyme Corporation Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) KEVZARA · Rheumatology | $2,862 |
| Genzyme Corporation Feb 27, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Charleston, SC · in-kind | $450 |
| Genzyme Corporation Feb 27, 2025 | Travel and Lodging KEVZARA · Rheumatology · travel to Charlston, SC · in-kind | $175 |
| Novartis Pharmaceuticals Corporation Jan 31, 2025 | Travel and Lodging travel to Houston, TX · in-kind | $537 |
| Novartis Pharmaceuticals Corporation Jan 31, 2025 | Travel and Lodging travel to Houston, TX · in-kind | $163 |
| Novartis Pharmaceuticals Corporation Jan 31, 2025 | Travel and Lodging travel to Houston, TX | $99.95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jan 14, 2025 | Consulting Fee OFEV · RESPIRATORY | $2,800 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jan 14, 2025 | Travel and Lodging OFEV · RESPIRATORY · travel to Aventura, FL · in-kind | $140 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 8 industry-funded studies in 2025, from 5 companies. The companies reported $584,620 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (POETYK SLE-2)
E.r. Squibb & Sons, L.l.c. - Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Eli Lilly and Company · Completed · NCT06588296 - A phase 2A, single-arm study to investigate the efficacy and safety of LY3541860 in adult participants with moderately-to-severely active rheumatoid arthritis
Eli Lilly and Company - A phase 4, multicenter, prospective, open-label study describing the e
GlaxoSmithKline, LLC. - A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
AbbVie Inc. · Recruiting · NCT06972446 - Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
AbbVie Inc. · Recruiting · NCT06865105 - A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals Corporation - A Phase 2, Multicenter, Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderately to Severely Active Rheumatoid Arthritis
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.